Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Cheng Liu
Engineered heparin-based biomaterials have emerged as a versatile and promising class of materials with diverse biomedical applications. Leveraging the inherent bioactivity of heparin and advances in material engineering, researchers have developed tailored biomaterials that exhibit unique properties for applications ranging from drug delivery and tissue engineering to wound healing and diagnostics [1]. This article provides a comprehensive overview of the multifaceted potential of engineered heparin-based biomaterials. It explores their design principles, interactions with biological systems, and implications for various biomedical domains. Through a synthesis of current research, this article highlights the transformative impact of these biomaterials and discusses their role in shaping the future of modern medicine [2].